Anaptysbio (ANAB) EBIT Margin (2016 - 2026)
Anaptysbio (ANAB) recorded EBIT Margin of -135.53% in Q1 2026, down 36.37 percentage points from -99.16% a year earlier and down 197.34 percentage points from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) EBIT Margin (2016 - 2026) Analysis & Trends
On a TTM basis, Anaptysbio's EBIT Margin came in at 17.56% as of Mar 31, 2026, up 107.20 percentage points year-over-year; for FY2025, it was 20.42%, up 146.35 percentage points from FY2024.
- Annual EBIT Margin has increased for three straight years, with a five-year change of +52.25 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -125.93% in FY2024 (+832.34 pp), -958.27% in FY2023 (+161.14 pp), -1119.41% in FY2022 (-1029.48 pp) and -89.93% in FY2021 (-58.09 pp).
- The Q1 2026 figure is the lowest quarterly EBIT Margin since Q2 2024.
- On a year-over-year basis, EBIT Margin rose in seven of the last eight quarters, with an average year-over-year change of +400.92 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 2700.29 percentage points in Q4 2022, against a drop of 3137.38 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 61.80% (Q4 2025), 45.47% (Q3 2025) and -117.55% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - | -135.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -135.53% |
| Dec 31, 2025 | 61.80% |
| Sep 30, 2025 | 45.47% |
| Jun 30, 2025 | -117.55% |
| Mar 31, 2025 | -99.16% |
| Dec 31, 2024 | -22.43% |
| Sep 30, 2024 | -75.81% |
| Jun 30, 2024 | -367.52% |
| Mar 31, 2024 | -587.84% |
| Dec 31, 2023 | -467.91% |
| Sep 30, 2023 | -1,137.19% |
| Jun 30, 2023 | -1,160.20% |
| Mar 31, 2023 | -3,231.51% |
| Dec 31, 2022 | -381.51% |
| Sep 30, 2022 | -2,291.80% |
| Jun 30, 2022 | -2,286.10% |
| Mar 31, 2022 | -3,273.09% |
| Dec 31, 2021 | -3,081.80% |
| Sep 30, 2021 | -32.37% |
| Jun 30, 2021 | -1.78% |
API Access
Anaptysbio EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();